| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |